Wednesday, July 8, 2026

pharma · ENVB

Enveric Biosciences

Enveric Biosciences drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

CAMBRIDGE, MA, USA HQ
Public company Type
ENVB · NYSE Ticker
Company details
Status
Public
HQ
CAMBRIDGE, MA, USA
Programs
0
Drugs
0
Patents
22
Intelligence · Drug Pipeline

Enveric Biosciences pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Enveric Biosciences drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →